Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
100% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $252.5K | $10.4K | $128.9K | $44.4K | $13.4K | $3.2K | $6.3K | $14 |
| Cost of revenue | $167.6K | $48.3K | $45.6K | $21.2K | $6.4K | $13.0K | $1.4K | $0 |
| Gross profit | $84.9K | −$37.9K | $83.3K | $23.2K | $7.0K | −$9.8K | $4.9K | $13 |
| Gross margin | 33.6% | -364.7% | 64.6% | 52.2% | 52.2% | -303.5% | 77.2% | 95.7% |
| R&D | $0 | $21.1K | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$1.7M | −$2.0M | −$2.7M | −$1.3M | −$7.4K | −$13.2K | −$362.4K | −$654 |
| EBITDA | $25.4K | −$2.1M | $6.2M | −$1.2M | −$713.8K | −$550.3K | −$362.5K | $0 |
| Net income | −$1.3M | −$5.1M | −$6.3M | −$2.2M | −$1.1M | −$1.2M | −$782.2K | −$1.0K |
| Net margin | -516.2% | -48712.4% | -4888.7% | -4910.0% | -8361.3% | -35960.0% | -12387.7% | -7460.4% |
| EPS (diluted) | -48186714.00 | -130.00 | -0.01 | -0.26 | -0.00 | -0.67 | -0.00 | -0.00 |
Annual figures · source: Financial Modeling Prep
INGEN TECHS INC
No one on the platform currently holds IGNT.
No tracked institution reports a position in IGNT as of their last filing.
No one on the platform has traded IGNT yet.
| $9220 |
| — |
| INFIQInfinity Pharmaceuticals, Inc. | $0.00 | +0.00% | $9076 | — |
| KKURChromoCure, Inc. | $0.00 | +0.00% | $8200 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.